SCI/PUBMED gelistet | alle Publikationstypen | Gesamt nach Jahr und Erstautor | MUG-Autor*innen |
** = Publikationen gelistet in SCI/SSCI/Pubmed
** Ehall, B; Herbsthofer, L; Obermüller, B; Karacay, C; Bounab, K; Franz, J; El-Heliebi, A; Boulgaropoulos, B; Bonstingl, L; Sallinger, K; Hois, V; Harer, C; Kotzbeck, P; Graier, WF; Schoiswohl, G; Prietl, B; Pieber, TR
Revisiting type 1 diabetes progression in the non-obese diabetic mouse.
Sci Rep. 2026;
Doi: 10.1038/s41598-026-35483-9
PubMed
FullText
FullText_MUG
** Meçani, R; Basta, S; Baumann, PM; Cigler, M; El, Hakouni, O; Hochfellner, DA; Shojaee-Moradie, F; Fan, KS; Tews, D; Pieber, TR; Russell-Jones, D; Mathieu, C; Koehler, G; Mader, JK, , EASA, Diabetes, Consortium
Performance of continuous glucose monitoring systems (CGMs) during commercial flights in T1DM: A within-subject comparative pilot study.
Diabetes Obes Metab. 2026;
Doi: 10.1111/dom.70418
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Buch, O; Cardoso, LM; Gittoes, N; Houillier, P; van, Hulsteijn, L; Makay, O; Marcocci, C; Pallais, JC; Rejnmark, L; Yavropoulou, M; Dekkers, OM; Bollerslev, J
Use of total calcium in hypoparathyroidism: A pragmatic approach but with limitations.
Eur J Endocrinol. 2025;
Doi: 10.1093/ejendo/lvaf262
Web of Science
PubMed
FullText
FullText_MUG
** Vejzovic, D; Karner, C; Fechter, K; Ritter, G; Holzer, V; Barones, L; Schweintzger, NA; Wagner, K; Lyssy, F; Gauster, M; Szkandera, J; Stanzer, S; Prietl, B; El-Heliebi, A; Lohberger, B; Guillén-Navaro, MJ; Avilés, PM; Brčić, I; Liegl-Atzwanger, B; Rinner, B
Drug screening reveals differential drug response in primary and metastatic clear cell sarcoma.
Cancer Lett. 2025; 218131
Doi: 10.1016/j.canlet.2025.218131
Web of Science
PubMed
FullText
FullText_MUG
** Glatz, U; Müller, A; Moser, O; Aberer, F; Niedrist, T; Herrmann, M; Zelzer, S; Jaruan, O; Sourij, C; Osto, E; Oettl, K; Paar, M; Pieber, T; Pferschy, P; Tripolt, N; Aziz, F; Sourij, H
Acute and prolonged effects of aerobic endurance training on N-lactoyl-phenylalanine and inflammatory markers in individuals with type 1 diabetes: An exploratory analysis of the ULTRAFLEXI-1 study.
Diabetes Obes Metab. 2026; 28(1): 771-774.
Doi: 10.1111/dom.70236
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ramirez-Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Azhar, K; Aziz, F; Müller, A; Sourij, C; Obermayer-Pietsch, B; Žukauskaitė, K; Horvath, A; Stadlbauer, V; Vajda, C; Fazekas, C; Leal, Garcia, S; Wagner-Skacel, J; Sourij, H
Impact of intermittent fasting on self-regulatory behaviour and sleep in participants with insulin-treated type 2 diabetes: A secondary analysis of the INTERFAST-2 randomised controlled trial.
Diabetes Obes Metab. 2026;
Doi: 10.1111/dom.70469
Web of Science
PubMed
FullText
FullText_MUG
** Meçani, R; Muka, T; Cigler, M; Basta, S; El-Hakouni, O; Baumann, PM; Sanchez, D; Olsen, MT; Mathieu, C; Pieber, TR; Koehler, G; Mader, JK
The use of diabetes technology under aviation conditions: A systematic review of human and in-vitro studies and future considerations.
Diabet Med. 2026; e70220
Doi: 10.1111/dme.70220
PubMed
FullText
FullText_MUG
** Pemberton, JS; Andrews, RC; Barnard-Kelly, K; Battelino, T; Danne, T; Heinemann, L; Kar, P; Lumb, A; Maahs, DM; Mader, JK; Mathieu, C; Mohan, V; Murphy, HR; Scott, EM; Sherr, JL; Smart, CE; Tauschmann, M; Williams, A; Wilmot, EG; Zaharieva, DP; Moser, O
International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoring.
Diabetes Obes Metab. 2026;
Doi: 10.1111/dom.70460
PubMed
FullText
FullText_MUG